Development for the Peritoneal Carcinomatosis Index (PCI) in Ovarian Cancer

A Clinical Trial to Develop a Peritoneal Carcinomatosis Index (PCI) in Ovarian

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01538498

Enrollment

134

Registered

2012-02-24

Start date

2008-04-30

Completion date

2013-02-28

Last updated

2013-03-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ovarian Cancer

Keywords

PCI, Ovarian cancer

Brief summary

* Primary objectives: To develop peritoneal carcinomatosis index (PCI) for ovarian cancer, tubal cancer and primary peritoneal cancer that can represent perioperative intraperitoneal tumor burden objectively * Secondary objectives: To establish the relationship and find out clinical significance between PCI, tumor location and tumor characteristics

Detailed description

Patients with primary ovarian cancer * Informed consent * Digital photography & Checking PCI (tumor size, number, and Characteristics) * Postoperative surveillance(tumor marker, image and physical examination) 1. Developing the best fitting PCI model to reflect recurrence-free survival and overall survival * Selection of items * Weighting by items and tumor characteristics 2. Analysis of prognostic impact of PCI compared to conventional staging system (FIGO stage) for ovarian cancer

Interventions

None listed

Study design

Observational model

CASE_ONLY

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

FEMALE

Healthy volunteers

Inclusion criteria

1. Preoperative clinical diagnosis of ovarian cancer, tubal cancer, and primary peritoneal carcinoma (all stage) 2. Available preoperative image study (CT and/or MRI and/or PET) 3. Patients who gave a written informed consent 4. Patients must be surgical candidate considering medical and psychological condition

Exclusion criteria

* Patients who refuse to participate or want to withdraw at anytime.

Design outcomes

Primary

Measure	Time frame
Devleopment for the peritoneal carcinomatosis index (PCI)	55 months

Countries

South Korea

Outcome results